Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'Kovar_K'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
M Sercl, J Kovarik, O Jar... Klinische Erfahrungen mit psilocybin (CY 39 Sandoz) Psych. Neuro. 1961
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Gouzoulis E, von Bardeleb... Neuroendocrine and cardiovascular effects of MDE in healthy volunteers Neuropsychopharmacol... 1993
Ensslin HK, Kovar KA, Mau... Toxicological detection of the designer drug 3,4-methylenedioxyethylam... J Chromatogr B Biome... 1996
Spitzer M, Thimm M, Herml... Increased activation of indirect semantic associations under psilocybi... Biol Psychiatry 1996
Ensslin HK, Maurer HH, Go... Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... Drug Metab Dispos 1997
Kovar KA Chemistry and pharmacology of hallucinogens, entactogens and stimulant... Pharmacopsychiatry 1998
Gouzoulis-Mayfrank E, Hee... Effects of the hallucinogen psilocybin on habituation and prepulse inh... Behav Pharmacol 1998
Lindenblatt H, Kraemer E,... Quantitation of psilocin in human plasma by high-performance liquid ch... J Chromatogr B Biome... 1998
Brunnenberg M, Lindenblat... Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major me... J Chromatogr B Biome... 1998
Sondermann N, Kovar KA Screening experiments of ecstasy street samples using near infrared sp... Forensic Sci Int 1999
Kramer E, Kovar KA On-line coupling of automated solid-phase extraction with high-perform... J Chromatogr B Biome... 1999
Gouzoulis-Mayfrank E, The... Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... Psychopharmacology (... 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Kreth KP,Kovar KA, Schwab... Identification of the Human Cytochromes P450 Involved in the Oxidative... Biochem Pharmacol 2000
Brunnenberg M, Kovar KA Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamph... J Chromatogr B Biome... 2001
Mayerhofer A, Kovar KA, S... Changes in serotonin, dopamine and noradrenaline levels in striatum an... Neuroscience Letters 2001
Spitzer M, Franke B, Walt... Enantio-selective cognitive and brain activation effects of N-ethyl-3,... Neuropharmacology 2001
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Meyer A, Mayerhofer A, Ko... Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... Neurosci Lett 2002
Meyer A, Mayerhofer A, Ko... Rewarding effects of the optical isomers of 3,4-methylenedioxy-methyla... Neurosci Lett 2002
Schmidt WJ, Mayerhofer A,... Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? Neurosci Lett 2002
Lebsanft HB, Mayerhofer A... Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... J Neural Transm 2003
Schneider RC, Kovar KA Analysis of ecstasy tablets: comparison of reflectance and transmittan... Forensic Sci Int 2003
Buechler J, Schwab M, Mik... Enantioselective quantitation of the ecstasy compound R- and S-N-ethyl... J Chromatogr B Analy... 2003